Fluorescence-Guided Surgery for Assessing Margins in Head and Neck Cancer
JAMA Surgery · 2025
DOI: 10.1001/jamasurg.2025.1815 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JAMA Surgery, 2025. Verfasst von Shravan Gowrishankar und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head & Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee. Hauptthemen laut MEDLINE: Margins of Excision, Head and Neck Neoplasms, Surgery, Computer-Assisted, Optical Imaging. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Importance Head and neck squamous cell cancer (HNSCC) is associated with a higher positive margin rate compared with most other cancers in surgical oncology. This rate has remained stagnant over the past 3 decades. Fluorescence-guided surgery (FGS) is a promising tool to address high positive margin rates in multiple solid tumor types, including HNSCC. This review summarizes data from a decade of FGS research in this tumor type to outline how fluorescence can help improve margin clearance, especially at the deep margin. The principles presented can be broadly applied using HNSCC as a model disease. Observations In contrast to the superficial mucosal margin, the deep margin is especially challenging for surgeons to visualize and contributes to the vast majority of positive margins and subsequent sequelae in HNSCC. Using fluorescence in vivo can highlight residual disease in the resection bed, while using fluorescence ex vivo can highlight how close the tumor margin is from the resection surface of the specimen, guiding sampling and further resection. Conclusions and Relevance Currently, there are several clinical trials investigating FGS to improve margin clearance in HNSCC, with many fluorescent agents already approved for use in other cancer types. As additional agents are brought into clinical use, it will be critical to understand how this technique will or will not improve oncological management in our patients. To address this important point, we present 2 key areas where surgeons will consider use of these FGS: to assess the peripheral mucosal margin and the deep surface of the tumor. We outline how in vivo and ex vivo fluorescence can be used for this purpose. We summarize data from multiple sources to explain how FGS is most likely to help with deep margin clearance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head & Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
- Department of Oral and Maxillofacial Surgery, Rijnstate Hospital Arnhem, Arnhem, the Netherlands.
- Department of Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
- Department of Otolaryngology-Head and Neck Surgery, UT Southwestern Medical Center, Dallas, Texas.
- Department of Otolaryngology-Head & Neck Surgery, Massachussetts Eye and Ear Infirmary, Boston, Massachusetts.
Zitieren
APA
Gowrishankar, S., Van Keulen, S., Mattingly, A., Tanaka, H., Topf, M., Mannion, K., Langerman, A., Rohde, S., Sinard, R., Choe, J., Sumer, B., Varvares, M., & Rosenthal, E. L. (2025). Fluorescence-Guided Surgery for Assessing Margins in Head and Neck Cancer. JAMA Surgery. https://doi.org/10.1001/jamasurg.2025.1815
Vancouver
Gowrishankar S, Van Keulen S, Mattingly A, Tanaka H, Topf M, Mannion K, et al. Fluorescence-Guided Surgery for Assessing Margins in Head and Neck Cancer. JAMA Surgery. 2025. doi:10.1001/jamasurg.2025.1815
BibTeX
@article{Gowrishankar2025,
author = {Gowrishankar, Shravan and Van Keulen, Stan and Mattingly, Aviva and Tanaka, Hidenori and Topf, Mike and Mannion, Kyle and Langerman, Alexander and Rohde, Sarah and Sinard, Robert and Choe, Jennifer and Sumer, Baran and Varvares, Mark and Rosenthal, Eben L},
title = {Fluorescence-Guided Surgery for Assessing Margins in Head and Neck Cancer},
journal = {JAMA Surgery},
year = {2025},
doi = {10.1001/jamasurg.2025.1815}
}
EUVIMED